SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-16-031871
Filing Date
2016-05-13
Accepted
2016-05-13 17:07:35
Documents
1
Period of Report
2016-05-09

Document Format Files

Seq Description Document Type Size
1 SIECZKAREK rdgdoc.html 4  
1 SIECZKAREK rdgdoc.xml 4 3822
  Complete submission text file 0001437749-16-031871.txt   5078
Mailing Address
Business Address
SIECZKAREK MARK M (Reporting) CIK: 0001188738 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 161649405

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations